James Parmelee touted these five stocks in July of 2006.
Parmelee, an analyst with Credit Suisse First Boston, recommended Avery Dennison (AVY), Glaxosmithkline (GSK), Kimberly Clark (KMB), Paychex (PAYX), Wal-Mart (WMT). After nearly one year, four of the five are up so far.
AVY > Then: $57.84. Now: $67.72. Change: +17.1%.
GSK > Then: $55.28. Now: $52.64. Change: -4.8%.
KMB > Then: $60.19. Now: $66.56. Change: +10.6%.
PAYX > Then: $33.81. Now: $42.67. Change: +26.2%
WMT > Then: $43.53. Now: $48.06. Change: +10.4%.
Overall, on a weighted basis, Parmelee's picks are up 11.9%. The big winner is Paychex, which is also his only selection with a P/E above 18. I like these stocks because they're fundamentally sound, fairly low risk and still climbing, with the exception of Glaxo.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment